Evidence map›Paper›PMID 40739429›Full record

ArticleHeredity2025

Both maternal and paternal genotypes modulate Wolbachia-induced cytoplasmic incompatibility in graham bean beetles.

Yuko Numajiri, Natsuko I Kondo, Yukihiko Toquenaga, Daisuke Kageyama

Abstract read
In one paragraph

Article in Heredity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yuko NumajiriInstitute of Agrobiological Sciences, National Agriculture and Food Research Organization, 1-2 Owashi, Tsukuba, Ibaraki, Japan. numajiri.yuko400@naro.go.jp.ORCID 0000-0001-8119-9848
Natsuko I KondoBiodiversity Division, National Institute for Environmental Studies, Tsukuba, Ibaraki, Japan.ORCID 0000-0002-0883-0506
Yukihiko ToquenagaFaculty of Life and Environmental Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan.ORCID 0000-0003-1825-3754
Daisuke KageyamaInstitute of Agrobiological Sciences, National Agriculture and Food Research Organization, 1-2 Owashi, Tsukuba, Ibaraki, Japan.ORCID 0000-0002-9026-9825

Funding

Cabinet Office, Government of Japan JPJ009237MEXT | Japan Society for the Promotion of Science (JSPS) 23570017
6 · The paper itself

Abstract

Cytoplasmic incompatibility (CI) is a phenomenon where embryonic development is disrupted-often leading to complete failure-when the female parent lacks the symbiont strain carried by the male parent. This mechanism, employed by maternally transmitted symbionts such as Wolbachia, facilitates their rapid spread within a host population. CI has significant potential as a tool for achieving population replacement or suppression, particularly targeting disease vectors and agricultural pests. While complete expression of CI is ideal for such applications, its intensity can vary. Despite extensive research on the symbiont genotypes, the influence of host genetic background on CI expression remains poorly understood. Here, we found that in the bean beetle Callosobruchus analis, the Wolbachia strain wCana2 induces weak CI in its native nuclear background but strong CI in a previously unassociated nuclear background. Crossing experiments reveal that the nuclear backgrounds of both male and female parents can significantly affect CI expression independent of Wolbachia titres in C. analis. These findings uncover novel perspectives on the host-symbiont interactions underlying CI and highlight the complexities to be addressed for its practical application.

Indexed as

ColeopteraWolbachiaAnimalsCytoplasmFemaleGenotypeMaleSymbiosis

Identifiers

PMID40739429
PMCPMC12316872

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.